Menu

University of North Texas Health Science Center to Repay Government $13 Million

The research center and medical school admittedly violated the rules in spending grants from the National Institutes of Health.

Feb 19, 2018
Ashley Yeager

WIKIMEDIA, MICHAEL BARERAThe University of North Texas (UNT) Health Science Center will pay the US government more than $13 million in reparations for mistakes made in spending money from National Institutes of Health (NIH) grants.

The research center and medical school, located in Fort Worth, Texas, discovered the errors in 2015, disclosed them to the government, and agreed to repay the money in a settlement last Friday (February 16), the Star-Telegram reports. From January 2011 through February 2016, the center made errors logging researchers’ time working on grant projects and overpaid them. The center cooperated in the investigation of the errors and in the settlement process, according to a statement released by the US Attorney’s Office in the North District of Texas.

“Integrity is one of our core values, and that means owning, correcting and learning from our mistakes,” UNT Health Science Center President Michael Williams says in a media release. “We’ve strengthened our internal controls to promote accountability and transparency.”

The center says that since the errors were identified it has hired new employees dedicated to compliance with the NIH requirements, improved its accounting procedures, and invested in new tools to track time and effort related to research grants.

February 2019

Big Storms Brewing

Can forests weather more major hurricanes?

Marketplace

Sponsored Product Updates

Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that its QXDx AutoDG ddPCR System, which uses Bio-Rad’s Droplet Digital PCR technology, and the QXDx BCR-ABL %IS Kit are the industry’s first digital PCR products to receive U.S. Food and Drug Administration (FDA) clearance. Used together, Bio-Rad’s system and kit can precisely and reproducibly monitor molecular response to treatment in patients with chronic myeloid leukemia (CML).
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today showcases new automation features of its ZE5 Cell Analyzer during the Society for Laboratory Automation and Screening 2019 International Conference and Exhibition (SLAS) in Washington, D.C., February 2–6. These capabilities enable the ZE5 to be used for high-throughput flow cytometry in biomarker discovery and phenotypic screening.
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Researchers to benefit from an innovative software-connected pipetting system, bringing improved reproducibility and traceability of experiments to life-science laboratories.
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Incorporated (NYSE: GLW) will showcase advanced 3D cell culture technologies and workflow solutions for spheroids, organoids, tissue models, and applications including ADME/toxicology at the Society for Laboratory Automation and Screening (SLAS) conference, Feb. 2-6 in Washington, D.C.